Single Cell Sample Preparation Patents: Leaders & Trends 2026
Single Cell Sample Preparation Patents: Who's Filing and Where the Claims Sit
Filing jumped 950% between 2021 and 2024, from 2 to 21 records, with 2019 still the single peak year at 22 — this is a field that surged, cooled, and is surging again. Filings were near zero in 2017, spiked to a peak of 22 in 2019, then climbed again from 2 in 2021 to 21 in 2024 — a 950% increase over that three-year span. The dip between the two peaks and the sharpness of the second climb both point to a field that periodically resets around new dissociation or preservation chemistries rather than filing at a steady rate.
- 1INSTITUTE OF SCIENCE TOKYO11
- 2CYTOVERA11
- 3MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH10
- 4BIOS THERAPY PHYSIOLOGICAL SYSTEMS FOR HEALTH SPA10
- 5TIZIANA LIFE SCI PLC9
See the full single cell sample preparation analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
How many patents exist for single cell sample preparation?
This dataset covers 132 published records filed between 2015 and the 2026-07-31 cut-off, drawn from a search combining tissue dissociation, nuclei isolation and sample preservation terms with dissociation stress response, cell type bias, viability threshold, fixation-compatible workflow, debris removal and transport stability concepts. That figure reflects records in scope for this specific search, not every patent that touches single-cell workflows generally. Because publication lags filing by roughly 18 months, the most recent one to two years understate true filing volume.
Who are the leading patent filers in single cell sample preparation?
The ranked leaders in this dataset span 48 companies, with the top assignee holding 11 records, fifth place holding 9, and tenth place holding 6. The top 5 assignees combined account for 38.6% of all 132 records, and the top 10 account for 64.4%. That is a defined leading cluster rather than a single dominant holder, so a freedom-to-operate review should look across several names, not just one.
Is filing activity in single cell sample preparation growing or slowing?
Filings grew sharply between 2021 and 2024, rising from 2 to 21 records, a 950% increase over that three-year span, following an earlier peak of 22 in 2019. It would be a mistake to read the lower counts in 2025 and 2026 as a slowdown, since publication lag of roughly 18 months means those years are still filling in. The pattern so far looks like periodic bursts rather than steady linear growth.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Single Cell Sample Preparation covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.